Top 20 Companies in Global Glucagon-Like Peptide-1 Agonists Market (20262035): Expert View By Spherical Insights RELEASE DATE: May 2026 Author: Spherical Insights According to a research report published by Spherical Insights & Consulting, The Global Glucagon-Like Peptide-1 Agonists Market size is projected to grow from USD 46.18 Billion in 2025 to USD 160.42 Billion by 2035, at a CAGR of 13.28% during the forecast period 20262035
Arturo Garca-Horsman, University of Helsinki, Finland Reviewed by Luis Del Valle, LSU Health Sciences Center New Orleans, USA
The headlines sound positive, but FDA has not approved BPC-157 or made its final decision
Imanishi T, Murry CE, Reinecke H, Hano T, Nishio I, Liles WC, Hofsta L, Kim K, O'Brien KD, Schwartz SM, Han DK
Their broad gene-regulatory capacity continues to make them a compelling subject for researchers aiming to uncover the full spectrum of their therapeutic and cosmetic research applications